Recently, a team of MIT engineers devised an innovative method of purification that can significantly reduce the cost of the purification step using nanotechnology.
One of the most expensive steps in manufacturing protein drugs such as antibodies or insulin is the purification step: isolating the protein from the bioreactor used to produce it.
MIT engineers devised a way to purify protein drugs during manufacturing. Their approach, which uses nanoparticles to rapidly crystallize proteins, could help make protein drugs more affordable and accessible, especially in developing countries.
In fall 2020, MIT’s School of Engineering and Takeda Pharmaceuticals Company Limited launched the MIT-Takeda Program, a collaboration to support members of the MIT community working at the intersection of artificial intelligence and human health. Hou